BioReperia have developed a unique Zebrafish technology platform and products in the market of Personalized Cancer Medicine and Drug Discovery.
Location: Sweden, Ostergotland, Linköping
Employees: 11-50
Total raised: $830.7K
Founded date: 2015
Investors 2
| Date | Name | Website |
| - | LiU Invest | liuinvest.... |
| - | Almi Inves... | almi.se |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 21.05.2019 | Series A | $830.7K | - |
Mentions in press and media 2
| Date | Title | Description |
| 21.10.2025 | Palisades Therapeutics Demonstrates Breakthrough Anti-Metastatic Activity in Advanced Prostate Cancer Models | Pop Test/Palisades Therapeutics PT150/PT157 Prostate Cancer Metastasis ASCO Poster 2025 Novel Compounds Show Superior Efficacy to Standard-of-Care Enzalutamide in 5-Day Zebrafish Platform Study PT150 could represent a first-in-class candida... |
| 03.06.2019 | Die Gewinner der Swissbiolabs Challenge stehen fest |